New England Journal of Medicine: Retatrutide Phase 2 trial results - The landmark study establishing retatrutide efficacy and safety across multiple dose groups New England Journal of Medicine: STEP 1 semaglutide trial results - The pivotal trial demonstrating semaglutide 2.4 mg weight loss efficacy ClinicalTrials.gov: Retatrutide TRIUMPH program - Current status and details of all ongoing Phase 3 retatrutide trials FDA prescribing information for Wegovy (semaglutide 2.4 mg) - Complete approved labeling including dosing, safety, and clinical data New England Journal of Medicine: SELECT cardiovascular outcomes trial - The trial demonstrating semaglutide 20% reduction in major cardiovascular events These primary sources should be the foundation for any serious evaluation of either compound
The blend is a compounded formulation, not an FDA-approved product
Treatment Options at EllieMD EllieMDs approach to treatment is built around customization, convenience, and access
The semaglutide plateau guide , why you are not losing weight on semaglutide , and why you are not losing weight on tirzepatide cover proven strategies for breaking through stalls
This led to the development of the GLP-1-based drug liraglutide, which was approved by the U.S
They help with weight loss, but there's also this fear that you'll also lose muscle
